Literature DB >> 19277540

Development and characterization of antibodies to carbohydrate antigens.

Jamie Heimburg-Molinaro1, Kate Rittenhouse-Olson.   

Abstract

Antibodies to carbohydrate antigens are critical for the study of bacteria, tumors, blood groups, and cell-cell adhesion interactions; for the analysis of viral, hormone, and toxin receptors; and, finally, for analysis of the glycosylation of recombinant proteins. However, antibodies to carbohydrate structures are more difficult to develop because of the T-cell-independent response to carbohydrates. This can result in the production of low affinity and difficult to work with IgM antibodies to these molecules. Screening technologies that include IgM antibodies can cause selections of antibodies with low-affinity binding sites because of the net avidity enhancement. Unfortunately, the low-affinity binding site can also have a similar affinity for unwanted structures. Production of antibodies using cellular extracts can result in antibodies that react with multiple related structures, and therefore the resultant bioassays have sensitivity or specificity problems. Protein conjugates of saccharides for the production of polyclonal and monoclonal antibodies to carbohydrate structures can be used to solve these problems. For monoclonal antibody development to oligosaccharides, mapping with closely related saccharides allows the determination of the areas of the saccharide to which the antibody binds so that conclusions can be made concerning which saccharide structures will cross-react. Determination of the reactivity of the produced antibodies with related saccharide structures is essential prior to utilization.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19277540     DOI: 10.1007/978-1-59745-022-5_24

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  9 in total

1.  Development of serum glycoproteomic profiling technique; simultaneous identification of glycosylation sites and site-specific quantification of glycan structure changes.

Authors:  Koji Ueda; Sachiko Takami; Naomi Saichi; Yataro Daigo; Nobuhisa Ishikawa; Nobuoki Kohno; Masaru Katsumata; Akio Yamane; Minoru Ota; Taka-Aki Sato; Yusuke Nakamura; Hidewaki Nakagawa
Journal:  Mol Cell Proteomics       Date:  2010-09       Impact factor: 5.911

2.  Alteration of Electrostatic Surface Potential Enhances Affinity and Tumor Killing Properties of Anti-ganglioside GD2 Monoclonal Antibody hu3F8.

Authors:  Qi Zhao; Mahiuddin Ahmed; Hong-fen Guo; Irene Y Cheung; Nai-Kong V Cheung
Journal:  J Biol Chem       Date:  2015-04-07       Impact factor: 5.157

3.  Role of O-glycosylation and expression of CD43 and CD45 on the surfaces of effector T cells in human T cell leukemia virus type 1 cell-to-cell infection.

Authors:  Dmitriy Mazurov; Anna Ilinskaya; Gisela Heidecker; Alexander Filatov
Journal:  J Virol       Date:  2011-12-14       Impact factor: 5.103

4.  Monoclonal antibody HBME-1 reacts with a minor subset of B cells with villous surface and can be useful in the diagnosis of hairy cell leukemia and other indolent lymphoproliferations of villous B lymphocytes.

Authors:  László Krenács; Judit Tóth-Lipták; Judit Demeter; Klára Piukovics; Zita Borbényi; Péter Gogolák; Eszter Sári; Enikő Bagdi
Journal:  Virchows Arch       Date:  2013-10-05       Impact factor: 4.064

5.  Wzi is an outer membrane lectin that underpins group 1 capsule assembly in Escherichia coli.

Authors:  Simon R Bushell; Iain L Mainprize; Martin A Wear; Hubing Lou; Chris Whitfield; James H Naismith
Journal:  Structure       Date:  2013-04-25       Impact factor: 5.006

6.  Proteomic basis of the antibody response to monkeypox virus infection examined in cynomolgus macaques and a comparison to human smallpox vaccination.

Authors:  Sarah Keasey; Christine Pugh; Alexander Tikhonov; Gengxin Chen; Barry Schweitzer; Aysegul Nalca; Robert G Ulrich
Journal:  PLoS One       Date:  2010-12-30       Impact factor: 3.240

7.  Characterization of the antifungal functions of a WGA-Fc (IgG2a) fusion protein binding to cell wall chitin oligomers.

Authors:  Susie Coutinho Liedke; Daniel Zamith Miranda; Kamilla Xavier Gomes; Jorge Luis S Gonçalves; Susana Frases; Joshua D Nosanchuk; Marcio L Rodrigues; Leonardo Nimrichter; José Mauro Peralta; Allan J Guimarães
Journal:  Sci Rep       Date:  2017-09-22       Impact factor: 4.379

8.  Monoclonal Antibodies Generated against Glycoconjugates Recognize Chemical Linkers.

Authors:  Jessica Ramadhin; Vanessa Silva-Moraes; Thomas Norberg; Donald Harn
Journal:  Antibodies (Basel)       Date:  2020-09-15

9.  In silico driven redesign of a clinically relevant antibody for the treatment of GD2 positive tumors.

Authors:  Mahiuddin Ahmed; Yehuda Goldgur; Jian Hu; Hong-Fen Guo; Nai-Kong V Cheung
Journal:  PLoS One       Date:  2013-05-16       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.